Jeffrey Dunn

Director at Theradaptive

Capital raised by Theradaptive

$36.2M+$36.2M latest round

1 Form D filing · first filed Jul 2026 · Frederick, MD

CURRENT ROLE: Director
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

TheradaptiveBiotech · Frederick, MDsince Jul 2026

Director

Listed on Theradaptive's Form D filings

Company filings

via EDGAR · Form D for Theradaptive1

DateCompanyFormAmountRole on filing

Jul 21, 2026TheradaptiveForm D+$36.2M—

Form DJul 21, 2026 · Theradaptive+$36.2Mnot a signer

Overview

Last filing Jul 21, 2026

Jeffrey Dunn is on file as Director at Theradaptive in Frederick, MD. Theradaptive has 1 Form D filing on record, $36.2M raised in total.

Teammates

Theradaptive · 1

Luis AlvarezPresidentSigner

Products

Theradaptive · 1

OsteoAdapt SPClinical-stage regenerative biologic

An investigational bone graft therapeutic powered by AMP2, a proprietary rhBMP-2 variant engineered for targeted, sustained bone regeneration. It is being developed as an alternative to autologous and allograft bone in lumbar spinal fusion, and is in the pivotal OASIS trial after FDA approval in April 2026 to advance from feasibility to a pivotal study.